Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02.
Ontology highlight
ABSTRACT: Standards of care for meningioma include surgical resection and radiotherapy whereas pharmacotherapy plays almost no role in this disease. We generated primary cultures from surgically removed meningiomas to explore the activity of a novel cyclin-dependent kinase inhibitor, TG02, in meningioma cell cultures. Tumor and cell cultures were characterized by mutation profiling and DNA methylation profiling. DNA methylation data were used to allot each sample to one out of six previously established meningioma methylation classes: benign (ben)-1, 2, 3, intermediate (int)-A, B, and malignant (mal). Four tumors assigned to the methylation class ben-2 showed the same class in culture whereas cultures from five non-ben-2 tumors showed a more malignant class in four patients. Cell cultures were unifo
SUBMITTER: von Achenbach C
PROVIDER: S-EPMC7490722 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA